Navigation Links
Hocoma Launches New Version of its Established Gait Training Device LokomatPro
Date:6/28/2011

ROCKLAND, Mass., June 28, 2011 /PRNewswire/ -- In strong collaboration with clinical research partners, Hocoma recently introduced a new and more compact version of the LokomatPro that offers greater system capabilities. Since the launch of Hocoma's first gait therapy device in 2001, the LokomatPro has established itself as an effective intervention for improving over-ground walking function in patients with neurological diseases and injuries resulting in gait impairment.

The new LokomatPro version was developed based on the needs and experience of patients and clinicians, as well as technological advances. The device provides extensive locomotion training to help trigger greater functional improvements in appropriate patients with spinal cord injury, stroke, brain injury and other neurological conditions. It features a new design and is equipped with the Augmented Feedback and a touch screen as a standard. In the future, upgrading options, including for example, additional degrees of freedom at the hip joint, sophisticated control strategy, higher gait speed, will extend the LokomatPro as a sophisticated gait training device supporting therapists and the patients in reaching their therapy goals. As in the preceding versions with the optional Pediatric Orthoses, the LokomatPro provides intensive locomotion therapy also for the treatment of children with cerebral palsy or other neurological disorders.

Over 300 Lokomat in over 50 countries worldwide

The Lokomat, a driven gait orthosis, is used for robotic gait training of neurological patients with movement disorders caused by stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, Parkinson's disease or other neurological diseases and injuries. The Lokomat has been available on the market since 2001 and has been a crucial improvement in the art and science of locomotion therapy. Currently, there are over 300 Lokomat systems successfully applied in over 50 countries worldwide. In the US about 90 systems are installed. The Kessler Foundation/Kessler Institute of Rehabilitation (West Orange, NJ) is the first center in the US using the new Lokomat generation to provide intensive gait training to patients for both clinical and research applications.

Hocoma

Hocoma was set up in 2000, as a spin-off of the Swiss University Hospital Balgrist. The company currently employs more than 130 people at its headquarters near Zurich, Switzerland and at its subsidiaries in the US and Singapore. Hocoma develops and produces therapy solutions for neurological patients with movement disorders caused by stroke, spinal cord injury, traumatic brain injury, multiple sclerosis or other neurological diseases and injuries as well as small children with cerebral palsy. The product range features devices for intensive locomotion therapy (Lokomat®, Andago®), functional therapy of the upper extremities (Armeo®) as well as early rehabilitation and patient mobilization (Erigo®). Hocoma's products are applied successfully in clinics and research institutes worldwide. This medical technology company has received many awards for start-up companies, and was honored with the "Red Herring 100 Global Award" in January 2010, as one of the hundred most innovative companies world-wide.

Media images: http://www.hocoma.com/en/about-us/media-center/media-images


'/>"/>
SOURCE Hocoma
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. American Pain Foundation Launches New Educational Campaign, "Explain Your Pain," to Help Hispanic Americans Better Understand Chronic Pain and Pain Management
2. ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities
3. MCRA Launches Compliance and Business Ethics Hotline
4. Mylan Launches First Generic Version of Entocort EC® Capsules
5. Neuland Labs Launches Expanded Peptide Manufacturing Capabilities at 22nd American Peptide Symposium
6. Transgenomic, Inc. Launches Best-in-Class Next-Generation Sequencing Test for Nuclear Mitochondrial Disorders at the 2011 United Mitochondrial Disease Foundation Meeting
7. Multiple Sclerosis Association of America Launches Mobile Phone App for the Multiple Sclerosis Community
8. Ethicon Endo-Surgery Launches ENSEAL® G2 Super Jaw
9. Lilly for Better Health™ Launches Enhanced Multi-Channel Patient Education Platform
10. Vinomis Laboratories Launches Vindurance Challenge to Substantiate Claims of Enhanced Physical Endurance with Use of Resveratrol and Quercetin
11. MedeAnalytics Launches Value-Based Purchasing Resource Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
(Date:6/23/2016)... Revolutionary technology includes multi-speaker listening to conquer ... in advanced audiology and hearing aid technology, has today ... world,s first internet connected hearing aid that opens up ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... , TwinLink™ - the first dual communication ...
(Date:6/23/2016)... June 23, 2016 The Biotechnology ... continues to present great opportunities to investors. Stock-Callers.com assesses ... Intrexon Corp. (NYSE: XON ), Vertex Pharmaceuticals ... (NASDAQ: ARNA ), and Regeneron Pharmaceuticals Inc. ... stocks and receive your complimentary trade alerts at: ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
Breaking Medicine News(10 mins):